U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07191561) titled 'Hepatic Lipid Metabolism-Alcohol Use Disorder' on Sept. 24.
Brief Summary: Patients with hepatic steatosis due to alcohol will be offered liver biopsies when they enter a detoxification program. The first biopsy will occur in the first week of admission and the second in the fourth week when the steatosis has resolved. The hepatic transcriptome will be compared,
Study Start Date: Nov. 28
Study Type: OBSERVATIONAL
Condition:
Alcohol Use Disorder
Intervention:
DIAGNOSTIC_TEST: Liver biopsy
Biopsy of the liver
Recruitment Status: NOT_YET_RECRUITING
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NID...